David Elsley, CEO Cardiol Therapeutics

Start > Testimonials > David Elsley, CEO Cardiol Therapeutics

The pandemic opens up the opportunity for us to conduct our studies in an accelerated manner, as there is great interest on the part of clinics and regulatory authorities to obtain effective drugs